110 related articles for article (PubMed ID: 4150813)
21. Effects of S-8527 (1,1-bis(4'-(1'-carboxy-1'-methylpropoxy)phenyl) cyclohexane), a new hypolipidemic compound, on cholesterol and lipoprotein metabolism in rats.
Suzuki K
Biochem Pharmacol; 1976 Feb; 25(3):325-8. PubMed ID: 1267828
[No Abstract] [Full Text] [Related]
22. Effects of dietary treatment with clofibrate, nafenopin or WY-14.643 on mitochondria and DNA in mouse liver.
Lundgren B; Bergstrand A; Karlsson K; DePierre JW
Biochim Biophys Acta; 1990 Aug; 1035(2):132-8. PubMed ID: 2393663
[TBL] [Abstract][Full Text] [Related]
23. Study of nafenopin, a hypolipidemic drug on liver metabolism.
Gerbracht U; Köpf G; Wüst G; Weisse G; Schlatterer B; Eigenbrodt E
Arch Toxicol Suppl; 1989; 13():304-8. PubMed ID: 2476106
[No Abstract] [Full Text] [Related]
24. Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Schladt L; Hartmann R; Timms C; Strolin-Benedetti M; Dostert P; Wörner W; Oesch F
Biochem Pharmacol; 1987 Feb; 36(3):345-51. PubMed ID: 2880593
[TBL] [Abstract][Full Text] [Related]
25. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative.
Wada S; Koizumi M; Sasahara K; Neichi T; Nakakimura H; Onoda F; Hata SI
Atherosclerosis; 1981; 40(3-4):263-71. PubMed ID: 7332605
[TBL] [Abstract][Full Text] [Related]
26. Effect of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on cholesterol oxidation by rat liver mitochondria.
Kritchevsky D; Tepper SA
Proc Soc Exp Biol Med; 1972 Apr; 139(4):1284-7. PubMed ID: 5023326
[No Abstract] [Full Text] [Related]
27. Increased hepatotoxicity of carbon tetrachloride by the hypolipidemic drug nafenopin in rats.
Charpentier D; Tuchweber B
Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):449-61. PubMed ID: 6289397
[TBL] [Abstract][Full Text] [Related]
28. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
Orton TC; Parker GL
Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
[TBL] [Abstract][Full Text] [Related]
29. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
[TBL] [Abstract][Full Text] [Related]
30. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
[TBL] [Abstract][Full Text] [Related]
31. Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.
Seifert J; Mostecká H
Carcinogenesis; 1988 Jan; 9(1):3-8. PubMed ID: 2446797
[TBL] [Abstract][Full Text] [Related]
32. Changes in the serum concentration of cholesterol, triglycerides and phospholipids in the mouse and rat after administration of either chlorcyclizine or phenobarbital.
Salvador RA; Atkins C; Haber S; Conney AH
Biochem Pharmacol; 1970 Apr; 19(4):1463-9. PubMed ID: 4398011
[No Abstract] [Full Text] [Related]
33. A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
Elwood JC; Richert DA; Westerfeld WW
Biochem Pharmacol; 1972 Apr; 21(8):1127-34. PubMed ID: 5034198
[No Abstract] [Full Text] [Related]
34. Effects of soybean phospholipid, chlorella phospholipid, and clofibrate on collagen and elastin synthesis in the aorta and on the serum and liver lipid contents in rats.
Hashimoto S; Setoyama T; Yokokura T; Mutai M
Exp Mol Pathol; 1982 Feb; 36(1):99-106. PubMed ID: 7198996
[No Abstract] [Full Text] [Related]
35. Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate.
Raza H; Levine WG
Drug Metab Dispos; 1986; 14(1):19-24. PubMed ID: 2868860
[TBL] [Abstract][Full Text] [Related]
36. Azoreduction of dimethylaminoazobenzene (DAB) in primary cultures of rat hepatocytes. Effect of hypolipidemic agents.
Stoddart AM; Levine WG
Drug Metab Dispos; 1990; 18(1):36-41. PubMed ID: 1970775
[TBL] [Abstract][Full Text] [Related]
37. A study on cerium-induced liver injury in rats after pretreatment with spironolactone, phenobarbital, pregnenolone-16 alpha-carbonitrile and nafenopin.
Bjondahl K
Arzneimittelforschung; 1978; 28(5):817-9. PubMed ID: 581962
[TBL] [Abstract][Full Text] [Related]
38. Hepatic triglyceride lipases--effect of clofibrate and halofenate.
Cenedella RJ
Biochem Pharmacol; 1976 Dec; 25(23):2657-61. PubMed ID: 10929
[No Abstract] [Full Text] [Related]
39. The hypolipidaemic effect of EPA is potentiated by 2- and 3-methylation.
Vaagenes H; Madsen L; Dyrøy E; Frøyland L; Willumsen N; Berge RK
Adv Exp Med Biol; 1999; 466():221-6. PubMed ID: 10709648
[No Abstract] [Full Text] [Related]
40. Further studies concerning the effects of clofibrate on respiration and oxidative phosphorylation of rat liver mitochondria.
Mackerer CR; Haettinger JR
Biochem Pharmacol; 1974 Dec; 23(23):3331-45. PubMed ID: 4374218
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
